STOCKHOLM , June 26, 2026 /PRNewswire/ -- The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and...Leia Mais
Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)
Reviewed by Redação
on
27.6.26
Rating: 5